Molecular genetics & genomic medicine · 2026
Heart Transplant for Noncompaction Cardiomyopathy in NONO-Related Syndromic Intellectual Disability.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Singer Julia S, Garczarczyk-Asim Dorota, Michel Miriam, Müller Thomas, Hackl Lukas, Janecke Andreas R
Аннотация
INTRODUCTION: Loss-of-function variants in NONO cause an X-linked syndromic neurodevelopmental disorder (MRXS34), characterized by developmental delay, corpus callosum abnormalities, dysmorphic features, feeding difficulties, and congenital heart disease, most commonly left ventricular noncompaction cardiomyopathy (LVNC). Long-term outcome data remain limited.
METHODS: A 14-year-old boy with LVNC and syndromic neurodevelopmental features underwent exome sequencing and subsequently NONO transcript analysis. A literature search was conducted using the terms "NONO variant" and "NONO mutation".
RESULTS: Exome sequencing identified a hemizygous NONO variant, c.348G>A, absent from population databases. This silent mutation was predicted in silico to cause exon 4 skipping, resulting in a frameshift and a premature termination codon p.(Asn52Argfs*31). This prediction was confirmed by RT-PCR, and it was demonstrated that the aberrant transcript was subject to nonsense-mediated mRNA decay. The patient displayed the characteristic NONO-associated phenotype with rapid cardiac deterioration requiring pulsatile left ventricular assist device implantation at 1 year of age, and orthotopic heart transplantation at 2 years of age. At 14 years, graft function remains stable. An emergency hemicolectomy due to volvulus was performed at 12 years of age. A literature search identified 32 live-born patients and 11 fetuses with NONO loss-of-function mutations. Intellectual disability, particularly affecting language development, LVNC, a recognizable facial phenotype, dystrophy, and lean habitus were nearly invariantly present.
CONCLUSION: This report further emphasizes the core phenotype caused by NONO loss-of-function, describes the second individual with heart transplantation, and indicates an underrecognized prevalence of gastrointestinal features.
METHODS: A 14-year-old boy with LVNC and syndromic neurodevelopmental features underwent exome sequencing and subsequently NONO transcript analysis. A literature search was conducted using the terms "NONO variant" and "NONO mutation".
RESULTS: Exome sequencing identified a hemizygous NONO variant, c.348G>A, absent from population databases. This silent mutation was predicted in silico to cause exon 4 skipping, resulting in a frameshift and a premature termination codon p.(Asn52Argfs*31). This prediction was confirmed by RT-PCR, and it was demonstrated that the aberrant transcript was subject to nonsense-mediated mRNA decay. The patient displayed the characteristic NONO-associated phenotype with rapid cardiac deterioration requiring pulsatile left ventricular assist device implantation at 1 year of age, and orthotopic heart transplantation at 2 years of age. At 14 years, graft function remains stable. An emergency hemicolectomy due to volvulus was performed at 12 years of age. A literature search identified 32 live-born patients and 11 fetuses with NONO loss-of-function mutations. Intellectual disability, particularly affecting language development, LVNC, a recognizable facial phenotype, dystrophy, and lean habitus were nearly invariantly present.
CONCLUSION: This report further emphasizes the core phenotype caused by NONO loss-of-function, describes the second individual with heart transplantation, and indicates an underrecognized prevalence of gastrointestinal features.